Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817160-26-000021 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 15, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
4,356
Total Value
$39,000.72
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 1,452 | $1.86 | $2,700.72 | 118,679 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Oct 15, 2026 | Sale | 1,452 | $25.00 | $36,300.00 | 117,227 | Direct | โ | View Details | |
Chief Scientific Officer | Employee Stock Option (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 1,452 | $0.00 | $0.00 | 59,406 | Direct | โ | View Details |